The expansion of genetic and genomic testing in clinical practice and research, and the growing market for direct-to-consumer genomic testing has led to increased awareness about the impact of this form of testing on insurance. Genetic or genomic information can be requested by providers of mutually rated insurance products, who may then use it when setting premiums or determining eligibility for cover under a particular product. Australian insurers are subject to relevant legislation and an industry led standard that was updated in 2019 to introduce a moratorium on the use of genetic test results in life insurance underwriting for policies
Download full-text PDF
Source
http://dx.doi.org/10.1017/thg.2023.11 DOI Listing Publication Analysis
Top Keywords
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!